Skip to content

Clinical trials

Phase 2 Peripheral Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Nervous System Diseases Phase: Phase 2 Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20041
20051
20061
20071
20092
20112
20123
20131
20142
20151
20202
20223
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated6
Active, not recruiting3
Recruiting3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)3
Academic and Community Cancer Research United2
NeurogesX2
Baylor Research Institute1
Beth Faiman1
Celularity Incorporated1
Columbia University1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Dogwood Therapeutics Inc.1
Donna Hammond, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Nervous System Diseases32
Pain9
Neuralgia8
Breast Neoplasms5
HIV Infections5
Acquired Immunodeficiency Syndrome3
Herpes Zoster3
Neoplasms3
AIDS-Related Complex2
Hyperalgesia2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.